| | | | | | | |
 | MODERNA, INC. | -1.23% | 2.11% | -28.24% | -6.02% | 121.52% | 49 138 |
| IQVIA HOLDINGS INC. | 1.31% | 0.41% | -0.43% | -7.03% | 36.39% | 37 854 |
| SEAGEN INC. | -0.10% | 0.88% | 51.89% | 39.48% | 31.54% | 36 599 |
| ALNYLAM PHARMACEUTICALS, INC. | -0.71% | 2.87% | -19.08% | 46.21% | 50.72% | 23 946 |
 | CELLTRION, INC. | -0.75% | -0.06% | 7.29% | 10.89% | -27.36% | 18 842 |
| ICON PUBLIC LIMITED COMPANY | -1.11% | 8.72% | 12.74% | -1.50% | 34.66% | 17 942 |
| BIO-TECHNE CORPORATION | -0.40% | -0.60% | -0.25% | -8.93% | 28.88% | 13 015 |
| QIAGEN N.V. | -1.23% | -0.35% | -7.94% | 0.68% | 4.75% | 10 469 |
| UNITED THERAPEUTICS CORPORATION | 0.76% | 5.58% | -21.29% | -4.27% | 77.03% | 10 254 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -0.78% | 2.57% | -8.62% | -18.05% | 11.59% | 10 191 |
| PROMETHEUS BIOSCIENCES, INC. | -0.02% | 0.10% | 80.73% | 614.85% | --.--% | 9 505 |
 | HANGZHOU TIGERMED CONSULTING CO., LTD | -3.15% | -3.41% | -24.33% | -3.29% | -6.40% | 9 153 |
 | BACHEM HOLDING AG | -3.17% | -4.04% | 14.65% | 22.39% | 96.88% | 7 574 |
| PHARMARON BEIJING CO., LTD. | -4.62% | 0.76% | -31.69% | -40.22% | -9.85% | 7 222 |
| MEDPACE HOLDINGS, INC. | 2.11% | 6.38% | 1.94% | 48.49% | 144.75% | 6 604 |
| | | | | | | |
| | Moyenne | -0.87% | 1.46% | 1.82% | 46.25% | 42.51% | |
| | Moyenne pondérée par Capi. | -0.58% | 1.62% | 1.68% | 29.24% | 49.14% | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
